X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
female (42) 42
index medicus (32) 32
oncology (32) 32
middle aged (30) 30
aged (26) 26
adult (23) 23
obstetrics & gynecology (21) 21
cancer (19) 19
aged, 80 and over (17) 17
endometrial cancer (15) 15
ovarian cancer (15) 15
carcinoma (14) 14
chemotherapy (14) 14
prognosis (14) 14
ovarian neoplasms - drug therapy (13) 13
surgery (13) 13
obstetrics and gynecology (12) 12
retrospective studies (12) 12
analysis (11) 11
research (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
laparoscopy (9) 9
survival (9) 9
care and treatment (8) 8
management (8) 8
oncology, experimental (8) 8
treatment outcome (8) 8
clinical trials (7) 7
health aspects (7) 7
immunohistochemistry (7) 7
neoplasm staging (7) 7
ovarian neoplasms - pathology (7) 7
recurrence (7) 7
women (7) 7
carboplatin - administration & dosage (6) 6
hematology, oncology and palliative medicine (6) 6
ovarian neoplasms - surgery (6) 6
paclitaxel - administration & dosage (6) 6
prospective studies (6) 6
reproductive biology (6) 6
combined modality therapy (5) 5
doxorubicin - administration & dosage (5) 5
endometrial neoplasms - pathology (5) 5
endometrial neoplasms - surgery (5) 5
hysterectomy (5) 5
male (5) 5
medicine & public health (5) 5
metastasis (5) 5
paclitaxel (5) 5
patients (5) 5
radiotherapy (5) 5
risk factors (5) 5
survival rate (5) 5
abridged index medicus (4) 4
adolescent (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
complications (4) 4
disease-free survival (4) 4
doxorubicin - analogs & derivatives (4) 4
drug administration schedule (4) 4
drug therapy (4) 4
follow-up studies (4) 4
italy (4) 4
laparoscopic surgery (4) 4
lymphadenectomy (4) 4
lymphatic metastasis (4) 4
mortality (4) 4
mutation (4) 4
neoplasm recurrence, local (4) 4
neoplasms, glandular and epithelial - drug therapy (4) 4
ovarian neoplasms - blood supply (4) 4
ovarian neoplasms - mortality (4) 4
pegylated liposomal doxorubicin (4) 4
platinum (4) 4
quality of life (4) 4
risk (4) 4
studies (4) 4
time factors (4) 4
tumors (4) 4
age factors (3) 3
angiogenesis (3) 3
article (3) 3
biological markers (3) 3
biomarkers, tumor - metabolism (3) 3
breast-cancer (3) 3
cancer patients (3) 3
carboplatin (3) 3
carcinoma, ovarian epithelial (3) 3
carcinoma, squamous cell - surgery (3) 3
cervical cancer (3) 3
cisplatin (3) 3
cisplatin - administration & dosage (3) 3
classification (3) 3
cohort studies (3) 3
disease progression (3) 3
elderly (3) 3
endometrial neoplasms - mortality (3) 3
endometrial neoplasms - therapy (3) 3
endometriosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3323 - 3329
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 10/2019, Volume 30, Issue 9, pp. 964 - 968
Elderly patients with ovarian cancer are an increasing population and many of them are frailty with an increased risk of postoperative complications,... 
Journal Article
by de Boer, Stephanie M and Powell, Melanie E and Mileshkin, Linda and Katsaros, Dionyssios and Bessette, Paul and Haie-Meder, Christine and Ottevanger, Petronella B and Ledermann, Jonathan A and Khaw, Pearly and Colombo, Alessandro and Fyles, Anthony and Baron, Marie-Helene and Jürgenliemk-Schulz, Ina M and Kitchener, Henry C and Nijman, Hans W and Wilson, Godfrey and Brooks, Susan and Carinelli, Silvestro and Provencher, Diane and Hanzen, Chantal and Lutgens, Ludy C H W and Smit, Vincent T H B M and Singh, Naveena and Do, Viet and D'Amico, Romerai and Nout, Remi A and Feeney, Amanda and Verhoeven-Adema, Karen W and Putter, Hein and Creutzberg, Carien L and McCormack, Mary and Whitmarsh, Karen and Allerton, Rozenn and Gregory, Deborah and Symonds, Paul and Hoskin, Peter J and Adusumalli, Madhavi and Anand, Anjana and Wade, Robert and Stewart, Alexandra and Taylor, Wendy and Kruitwagen, Roy F.P.M and Hollema, Harry and Pras, Elizabeth and Snyers, An and Stalpers, Lukas and Jobsen, Jan J and Slot, Annerie and Mens, Jan-Willem M and Stam, Tanja C and Van Triest, Baukelien and Van der Steen - Banasik, Elzbieta M and De Winter, Karin A.J and Quinn, Michael A and Kolodziej, Ilka and Pyman, Jan and Johnson, Carol and Capp, Anne and Fossati, Roldano and Gribaudo, Sergio and Lissoni, Andrea A and Ferrero, Annamaria and Artioli, Grazia and Davidson, Cathy and McLachlin, C. Meg and Ghatage, Prafull and Rittenberg, Paula V.C and Souhami, Luis and Thomas, Gillian and Duvillard, Pierre and Berton-Rigaud, Dominique and Tubiana-Mathieu, Nicole and PORTEC Study Grp and PORTEC study group
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 295 - 309
Journal Article
Nature Communications, ISSN 2041-1723, 12/2016, Volume 7, Issue 1, p. 13730
The role of mitochondria in cancer is controversial. Using a genome-wide shRNA screen, we now show that tumours reprogram a network of mitochondrial dynamics... 
BREAST-CANCER | MIGRATION | CELLS | EVOLUTION | THERAPY | PATHWAY | MULTIDISCIPLINARY SCIENCES | IMAGE-ANALYSIS | TRACKING | TRAFFICKING
Journal Article
ANTICANCER RESEARCH, ISSN 0250-7005, 09/2019, Volume 39, Issue 9, pp. 5053 - 5056
Primary ovarian carcinoids are very rare tumors that belong to the germ cell family of ovarian malignancies. They account for less than 1% of all carcinoid... 
Strumal carcinoid | ovary | MANAGEMENT | bilateral mature cystic teratoma | ONCOLOGY | IOTA simple rules | neuroendocrine tumor | malignant strumal carcinoid | primary ovarian carcinoid | TUMORS | lymph node metastasis | Literature reviews | Teratoma | Aorta | Metastasis | Neoplasms | Lymph nodes | Tumors | Metastases
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4, pp. 320 - 326
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 01/2019, Volume 29, Issue 1, pp. 181 - 187
ObjectivesThis survey assessed the implementation of enhanced recovery after surgery (ERAS) for patients undergoing surgery for advanced ovarian cancer in... 
survey | enhanced recovery | fast­track | ovarian cancer | perioperative care
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2017, Volume 216, Issue 6, pp. 592.e1 - 592.e11
Journal Article
Journal of Minimally Invasive Gynecology, The, ISSN 1553-4650, 2016, Volume 23, Issue 1, pp. 53 - 61
Journal Article
Anticancer Research, ISSN 0250-7005, 03/2018, Volume 38, Issue 3, p. 1695
Background/Aim: To assess the patterns of recurrence of node-positive endometrial cancer patients. Patients and Methods: This investigation assessed 82... 
Endometrial cancer | Vagina | Radiation therapy | Patients | Survival | Nodes | Chemotherapy | Platinum | Paclitaxel | Aorta | Endometrium | Cancer | Tumors
Journal Article
Anticancer Research, ISSN 0250-7005, 07/2016, Volume 36, Issue 7, pp. 3445 - 3449
Aim: The aim of the study was to evaluate the incidence of endometriosis-associated ovarian cancer (EAOC) and compare clinicopathological characteristics and... 
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 206, pp. e7 - e7
Journal Article
European Journal of Obstetrics and Gynecology, ISSN 0301-2115, 11/2016, Volume 206, p. e170
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 206, pp. e170 - e170
Journal Article
Journal of Ovarian Research, ISSN 1757-2215, 02/2019, Volume 12, Issue 1, pp. 17 - 17
Relapsed epithelial ovarian cancer (EOC) is frequently treated with pegylated liposomal doxorubicin (PLD). Unfortunately, most patients do not benefit from... 
Topoisomerase 2 alpha | Pegylated liposomal doxorubicin | Ovarian cancer | SURVIVAL | TOPOISOMERASE-II-ALPHA | PHASE-III | CHEMOTHERAPY | BREAST-CANCER | LIPOSOMAL DOXORUBICIN | REPRODUCTIVE BIOLOGY | GENE | PROTEIN EXPRESSION | RESISTANCE | TRABECTEDIN | DNA Topoisomerases, Type II - metabolism | Doxorubicin - therapeutic use | Humans | Middle Aged | Carcinoma, Ovarian Epithelial - metabolism | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols | Drug Resistance, Neoplasm | Polyethylene Glycols - therapeutic use | Carcinoma, Ovarian Epithelial - pathology | Antibiotics, Antineoplastic - therapeutic use | Carcinoma, Ovarian Epithelial - drug therapy | Doxorubicin - analogs & derivatives | Biomarkers, Tumor - metabolism | DNA Topoisomerases, Type II - genetics | Female | Ovarian Neoplasms - metabolism | Retrospective Studies | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Patient outcomes | Drug therapy | Biological markers | Health aspects | Doxorubicin | DNA topoisomerase II | Testing | Immunohistochemistry | DNA topoisomerase (ATP-hydrolysing) | Statistical analysis | Disease | Feasibility studies | Breast cancer | Paraffin | Patients | Cancer therapies | Proteins | Chemotherapy | Gene amplification | Platinum | Medical prognosis | Protein expression | Index Medicus
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 03/2019, Volume 29, Issue 3, pp. 599 - 604
ObjectiveThe main objective is to develop a model based on computed tomographic features to predict surgical outcome and establish cut-offs to rationalize... 
advanced ovarian carcinoma | computed tomography | debulking surgery | predictive score | CYTOREDUCTIVE SURGERY | ONCOLOGY | PREDICT | ABILITY | PRIMARY DEBULKING | CA-125 | FALLOPIAN-TUBE | STAGE-III | SCAN | CARCINOMA | LAPAROSCOPY | OBSTETRICS & GYNECOLOGY
Journal Article